HCW Biologics (HCWB) Q3 2024 Earnings
HCWB·Reported November 14, 2024·Before market open
HCW Biologics reported Q3 2024 revenue of $426.4K. Diluted EPS came in at $-4.00, beat the $-5.20 consensus by $1.20.
Revenue
$426.4K
Diluted EPS
$-4.00beat by $1.20
Consensus: $-5.20
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about HCW Biologics's Q3 2024 earnings report.
HCW Biologics (HCWB) reported Q3 2024 earnings on November 14, 2024 before market open.
HCW Biologics reported revenue of $426.4K and diluted EPS of $-4.00 for Q3 2024.
EPS beat the consensus estimate of $-5.20 by $1.20.
You can read the 10-Q periodic report (0000950170-24-127198) directly on SEC EDGAR. The filing index links above go to sec.gov.